This page lists all pharmaceutical reports related to the field of Oncology. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 203 results
- In Vitro Diagnostics Market Analysis 2009-2024
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
- Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- Molecular Diagnostics in Cancer Testing
- The Worldwide Market for Cancer Diagnostics - 2010
- The Worldwide Market for Cancer Diagnostics
- The Market for Prescription Dermatological Drugs
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Biomarkers in Breast Cancer, 2010
- Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- Oncology Market Leaders – Analyses and Outlook – 2010-2025
- Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
- Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
- Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
- Mammography World Markets
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition
- Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020
- Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
- Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017
- Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020
- Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
- US Pharmaceutical Market Outlook 2011-2021
- Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
- Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
- Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
- In-vitro and Companion Diagnostics Industry - 2010 Yearbook
- Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
- The Future of In Vitro and In Vivo Diagnostic Integration
- Stakeholder Opinions: Melanoma
- Epidemiology: Cervical Cancer
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits